Penumbra Revenue 2014-2019 | PEN
Penumbra annual/quarterly revenue history and growth rate from 2014 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Penumbra revenue for the quarter ending September 30, 2019 was $0.140B, a 24.77% increase year-over-year.
- Penumbra revenue for the twelve months ending September 30, 2019 was $0.523B, a 24.45% increase year-over-year.
- Penumbra annual revenue for 2018 was $0.445B, a 33.31% increase from 2017.
- Penumbra annual revenue for 2017 was $0.334B, a 26.75% increase from 2016.
- Penumbra annual revenue for 2016 was $0.263B, a 41.5% increase from 2015.
| Penumbra Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $445 |
| 2017 | $334 |
| 2016 | $263 |
| 2015 | $186 |
| 2014 | $126 |
| 2013 | $89 |
| Penumbra Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q3 2019 | $140 |
| Q2 2019 | $134 |
| Q1 2019 | $128 |
| Q4 2018 | $121 |
| Q3 2018 | $112 |
| Q2 2018 | $110 |
| Q1 2018 | $103 |
| Q4 2017 | $96 |
| Q3 2017 | $84 |
| Q2 2017 | $81 |
| Q1 2017 | $73 |
| Q4 2016 | $73 |
| Q3 2016 | $67 |
| Q2 2016 | $65 |
| Q1 2016 | $58 |
| Q4 2015 | $54 |
| Q3 2015 | $50 |
| Q2 2015 | $42 |
| Q1 2015 | $39 |
| Q4 2014 | |
| Q3 2014 | $32 |
| Q4 2013 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.832B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $118.681B | 24.58 |
| Intuitive Surgical (ISRG) | United States | $63.491B | 49.90 |
| Edwards Lifesciences (EW) | United States | $49.921B | 45.33 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $22.137B | 14.98 |
| IDEXX Laboratories (IDXX) | United States | $22.090B | 53.42 |
| Olympus (OCPNY) | Japan | $21.701B | 162.97 |
| DexCom (DXCM) | United States | $18.868B | 168.97 |
| Teleflex (TFX) | United States | $15.367B | 31.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.903B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.384B | 38.72 |
| STERIS (STE) | Ireland | $12.344B | 27.27 |
| Hologic (HOLX) | United States | $12.336B | 18.91 |
| Varian Medical Systems (VAR) | United States | $11.335B | 26.83 |
| ABIOMED (ABMD) | United States | $10.094B | 54.92 |
| Masimo (MASI) | United States | $7.778B | 46.44 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Elekta AB (EKTAY) | Sweden | $5.597B | 43.09 |
| Globus Medical (GMED) | United States | $5.474B | 33.89 |
| Integra LifeSciences Holdings (IART) | United States | $5.013B | 21.54 |
| Wright Medical Group (WMGI) | Netherlands | $3.731B | 326.67 |
| LivaNova (LIVN) | United Kingdom | $3.686B | 26.54 |
| Tandem Diabetes Care (TNDM) | United States | $3.630B | 0.00 |
| Nevro (NVRO) | United States | $3.226B | 0.00 |
| Cantel Medical (CMD) | United States | $3.043B | 30.73 |
| Integer Holdings (ITGR) | United States | $2.478B | 16.96 |
| Nihon Kohden (NHNKY) | Japan | $2.401B | 24.16 |
| Glaukos (GKOS) | United States | $2.339B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.620B | 31.88 |
| Inogen (INGN) | United States | $1.519B | 47.95 |
| Veracyte (VCYT) | United States | $1.159B | 0.00 |
| Natus Medical (NTUS) | United States | $1.117B | 26.85 |
| Silk Road Medical (SILK) | United States | $1.098B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.016B | 37.67 |
| Tactile Systems Technology (TCMD) | United States | $1.005B | 114.78 |
| OPKO Health (OPK) | United States | $0.952B | 0.00 |
| Luminex (LMNX) | United States | $0.902B | 0.00 |
| CryoLife (CRY) | United States | $0.882B | 90.46 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.857B | 28.46 |
| Accelerate Diagnostics (AXDX) | United States | $0.839B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.704B | 0.00 |
| Intersect ENT (XENT) | United States | $0.658B | 0.00 |
| AxoGen (AXGN) | United States | $0.608B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.577B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.564B | 20.24 |
| Quotient (QTNT) | Switzerland | $0.540B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.445B | 13.45 |
| Si-Bone (SIBN) | United States | $0.435B | 0.00 |
| Sientra (SIEN) | United States | $0.425B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.421B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.328B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.297B | 41.36 |
| IRadimed (IRMD) | United States | $0.275B | 38.56 |
| SeaSpine Holdings (SPNE) | United States | $0.251B | 0.00 |
| ViewRay (VRAY) | United States | $0.244B | 0.00 |
| Accuray (ARAY) | United States | $0.239B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.231B | 64.40 |
| Stereotaxis (STXS) | United States | $0.223B | 0.00 |
| Fluidigm (FLDM) | United States | $0.165B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.148B | 40.20 |
| ConforMIS (CFMS) | United States | $0.135B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 66.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.090B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.087B | 0.00 |
| TransEnterix (TRXC) | United States | $0.078B | 0.00 |
| Vermillion (VRML) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
| Electromed (ELMD) | United States | $0.060B | 21.51 |
| Apollo Endosurgery (APEN) | United States | $0.059B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.054B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.046B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.042B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.028B | 0.00 |
| Nuvectra (NVTR) | United States | $0.025B | 0.00 |
| Neovasc (NVCN) | Canada | $0.023B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.023B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.021B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.020B | 0.00 |
| Restoration Robotics (VERO) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 20.50 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.011B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.011B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.009B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| InspireMD (NSPR) | Israel | $0.001B | 0.00 |
